Table 3.

Placenta fatty acid profile from cows supplemented with saturated fat, flaxseed oil, or fish oil

FA, %	Treatment1			SEM	P-value
	CTL	FLX	FO
C14:02	1.40	1.22	1.37	0.06	0.15
C16:02	27.43	25.31	26.84	1.53	0.62
C16:12	0.84b	2.71ab	3.83a	0.58	0.03
C16:22	6.68a	1.53b	0.85b	1.02	0.0002
C16:32	0.08	0.14	0.04	0.05	0.52
C18:02	9.78	14.89	12.72	2.80	0.48
C18:1n-92	37.10	33.53	35.39	2.71	0.67
C18:1n-72	0.26	0.22	0.16	0.04	0.33
C18:2n-62	7.25	8.75	8.96	1.43	0.67
C18:3n-3 (ALA)2	4.66	5.52	4.75	0.40	0.32
C20:4n-62	4.22	4.28	3.17	0.91	0.64
C20:5n-3 (EPA)2	0.79	0.87	0.57	0.13	0.31
C22:5n-32	0.03	0.04	0.05	0.01	0.45
C22:6n-3 (DHA)2	1.16	0.98	1.30	0.17	0.47
SFA	38.62	41.42	40.94	1.53	0.43
MUFA	38.20	36.46	39.37	2.29	0.68
PUFA	23.18	22.12	19.69	1.19	0.18
Total n-3 FAs	6.64	7.41	6.66	0.60	0.61
Total n-6 FAs	11.48	13.03	12.13	1.87	0.84
n-6:n-3 FAs ratio	1.71	1.76	1.94	0.36	0.89

¹Dairy cows at d 257 of pregnancy were divided into three nutritional groups supplemented with (i) CTL – encapsulated saturated fat, (ii) FLX – encapsulated flaxseed oil providing ALA, or (iii) FO – encapsulated fish oil providing EPA and DHA

²C14:0 to C22:6n-3: % of total FAs identified

ALA Alpha-linolenic acid, DHA Docosahexaenoic acid, EPA Eicosapentaenoic acid, FAs Fatty acids, SFA Saturated FA, MUFA Monounsaturated FA, PUFA Polyunsaturated FA

^a,bValues with different superscript letters in a row are significantly different at P ≤ 0.05